Links

FIELD: pharmaceutical industry. SUBSTANCE: biologically active compounds, namely the use of 2-(pyren-1-yl)naphtho[1,2-d]oxazolyl-5-sulfonic acid. EFFECT: use of 2-(pyren-1-yl)naphtho[1,2-d]oxazolyl-5-sulfonic acid as a monomolecular agent for generating radical oxygen species. 1 cl, 4 dwg.
Translated title of the contributionApplication of 2-(Pyrene-1-Yl)Naphtho[1,2-D]Oxazolyl-5-Sulfic Acid As a Monomolecular Agent for Photodynamic Therapy: patent of invention
Original languageRussian
Patent number2795221
IPCC07D 263/60,A61K 31/423,A61P 31/00,A61P 35/00
Priority date28/07/2022
Filing date28/07/2022
Publication statusPublished - 2 May 2023

ID: 47015325